NASDAQ · OKYO
OKYO Pharma Limited
$1.50+$0.01 (+0.67%)
OKYO Pharma Limited’s quoted price sits in the lower half of its reported 52-week range, 53.13% below the high.
Loading market information…
OTC · PCHM · USD
Stock price, dividends, earnings
Quote as of Aug 28, 2025, 06:42 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
PharmChem, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.78% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
PharmChem, Inc.’s forward annual dividend is $0.12 per share, paid annual. The forward yield is 3.2% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow PharmChem, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
PharmChem, Inc. manufactures and distributes the PharmChek Sweat Patch, a product designed for detecting the presence of illicit substances. This patch uses sweat as its sample source, offering an innovative alternative to conventional urine drug tests for identifying cocaine, opiates, amphetamines, PCP, and marijuana. The company is headquartered in Fort Worth, Texas.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:27 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.50+$0.01 (+0.67%)
OKYO Pharma Limited’s quoted price sits in the lower half of its reported 52-week range, 53.13% below the high.
¥57-¥1 (-1.72%)
Kubota Pharmaceutical Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 83.71% below the high.
$0.08$0.00 (0.0%)
Renalytix Plc’s quoted price sits in the lower half of its reported 52-week range, 87.52% below the high.
$1.04+$0.04 (+3.5%)
U.S. NeuroSurgical Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 46.65% below the high.
$0.39-$0.00 (-0.39%)
HS GovTech Solutions Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.22% below the high.
$0.00$0.00 (0.0%)
Yourgene Health Plc: Healthcare · Medical - Diagnostics & Research.
$0.15-$0.01 (-8.96%)
Vinergy Capital Inc.’s quoted price sits in the upper half of its reported 52-week range, 48.39% below the high.
$0.16-$0.03 (-15.36%)
TPCO Holding Corp.’s quoted price sits in the lower half of its reported 52-week range, 83.81% below the high.
